首页> 美国卫生研究院文献>Brazilian Journal of Medical and Biological Research >Long-term efficacy of endovascular vs open surgical repair forcomplicated type-B aortic dissection: a single-center retrospective study andmeta-analysis
【2h】

Long-term efficacy of endovascular vs open surgical repair forcomplicated type-B aortic dissection: a single-center retrospective study andmeta-analysis

机译:腔内与开放手术修复的长期疗效复杂的B型主动脉夹层:单中心回顾性研究和荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study aimed to evaluate the long-term survival and risk factors of traditional open surgical repair (OSR) vs thoracic endovascular aneurysm repair (TEVAR) for complicated type-B aortic dissection (TBAD). A total of 118 inpatients (45 OSR vs 73 TEVAR) with TBAD were enrolled from January 2004 to January 2015. Kaplan-Meier curves and Cox proportional hazards analysis were performed to identify the long-term survival rate and independent predictors of survival, respectively. Meta-analysis was used to further explore the long-term efficacy of OSR and TEVAR in the eight included studies using Review Manager 5.2 software. An overall 10-year survival rate of 41.9% was found, and it was similar in the two groups (56.7% OSR vs 26.1% TEVAR; log-rank P=0.953). The risk factors of long-term survival were refractory hypertension (OR=11.1; 95%CI=1.428-86.372; P=0.021] and preoperative aortic diameter >55 mm (OR=4.5; 95%CI=1.842-11.346; P=0.001). Long-term survival rate did not differ significantly between OSR and TEVAR (hazard ratio=0.87; 95%CI=0.52-1.47; P=0.61). Compared with OSR, TEVAR did not show long-term advantages for patients with TBAD. Refractory hypertension and total aortic diameter >55 mm can be used to predict the long-term survival of TBAD in theChinese Han population.
机译:这项研究旨在评估复杂的B型主动脉夹层(TBAD)的传统开放手术修复(OSR)与胸腔内血管瘤修复(TEVAR)的长期生存和危险因素。从2004年1月至2015年1月,共纳入118例TBAD住院患者(45 OSR vs 73 TEVAR)。分别进行了Kaplan-Meier曲线和Cox比例风险分析,以识别长期生存率和独立的生存预测因子。使用Review Manager 5.2软件通过荟萃分析进一步探讨了OSR和TEVAR的长期疗效,共纳入了八项研究。发现总的10年生存率为41.9%,两组相似(OSR为56.7%,TEVAR为26.1%;对数秩P = 0.953)。长期生存的危险因素是难治性高血压(OR = 11.1; 95%CI = 1.428-86.372; P = 0.021]和术前主动脉直径> 55 mm(OR = 4.5; 95%CI = 1.842-11.346; P = 0.001)。OSR和TEVAR之间的长期生存率无显着差异(危险比= 0.87; 95%CI = 0.52-1.47; P = 0.61)。与OSR相比,TEVAR对患有OSR的患者无长期优势TBAD:难治性高血压和主动脉总直径> 55 mm可用于预测TBAD在患者中的长期存活。中国汉族人口。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号